NEW YORK (GenomeWeb) – The Alliance Global Group (AGBL) today announced an exclusive master distribution agreement for Fluxion Biosciences' IsoFlux and BioFlux systems in emerging markets in the Middle East, Asia, and Africa.

The IsoFlux Cell Separation System allows researchers to detect variants in circulating tumor cells by next-generation sequencing. The BioFlux System is for the introduction of flow conditions into research and drug discovery experiments to emulate the in vivo environment.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.